- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03622294
A Clinical Analysis of Bella Blankets® Protective Coverlets
A Clinical Analysis of Bella Blankets® Protective Coverlets Used to Increase the Image Quality of Mammograms, Aid as a Quality Standard for EQUIP Clinical Image Quality (CIQ) Compliance Measurements and Improve Patient Satisfaction.
This study will collect and compare clinical image quality measurements of randomly scheduled, asymptomatic, screening mammography patients, right breast mammogram performed with and without the use of Bella Blankets protective coverlets on the receptor plate.
The measurements will determine if the use of Bella Blankets protective coverlets increases the mammogram's clinical image quality and if Bella Blankets protective coverlets can be used as an aid for EQUIP compliance.
In addition, a patient satisfaction survey will be conducted with participants to determine if the use of Bella Blankets protective coverlets improves patient satisfaction.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14620
- Elizabeth Wende Breast Care, LLC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject is Female of any race and ethnicity
- Subject is 40-75 years old
- Subject is scheduled for a screening mammogram
- Subject is willing and able to understand and read the Informed consent form
- Subject has been a patient at Elizabeth Wende Breast Care for 2 years or more
Exclusion Criteria:
- Subject is Male
- Subject has been a patient at Elizabeth Wende Breast Care for less than 2 years
- Subject has had a breast biopsy within the last 2 years
- Subject has had breast surgery within the last 2 years
- Subject is scheduled for a Diagnostic mammogram
- Subject suspects or may be pregnant
- Subject is currently pregnant or breastfeeding
- Subject has breast implants
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Right Breast Mammogram Measurements and Survey
A right breast screening mammogram will be performed with Bella Blankets protective coverlets on the imaging receptor plate, then removed from the equipment. The screening mammogram continues with a left breast and second right breast screening mammogram on a bare imaging receptor plate. Clinical image quality measurements for the right breast mammograms will automatically be captured by VolparaEnterprise for a comparative analysis. A patient satisfaction survey will be completed by each participant and the results will be analyzed. |
Bella Blankets protective coverlets is a Class II 510(k) Cleared (2008) single-use, adhering, non-woven fabric sheet applied to the mammography equipment receptor plate to provide a more comfortable mammogram.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Image Quality (CIQ) Outcomes of a Participant's Right Breast Mammogram Performed with Bella Blankets Protective Coverlets on the Receptor Plate to a Bare Receptor Plate.
Time Frame: Through the completion of 100 participants; approximately 4 months
|
Comparison of the Clinical Image Quality (CIQ) analytics, automatically captured by VolparaEnterprise, for the participant's right breast mammogram performed on a receptor plate with Bella Blankets protective coverlets to the same right breast mammogram performed on a bare receptor plate during the same screening mammogram visit.
|
Through the completion of 100 participants; approximately 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction Survey
Time Frame: Through the completion of 100 participants; approximately 4 months
|
A questionnaire completed by the participant after their mammogram and prior to exit.
The one-page questionnaire requires the participant answers each question by selecting one Likert Scale option about their experience with the use and without the use of Bella Blankets protective coverlets.
|
Through the completion of 100 participants; approximately 4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment as an Aid to Achieve Standards for Mammogram EQUIP Compliance Measurements.
Time Frame: At the completion of 100 participants; approximately 4 months from study initiation
|
An assessment by the Principal Investigator,based on CIQ results and the FDA CIQ EQUIP standards, determining if Bella Blankets protective coverlets can be used by technologists to aid in achieving EQUIP compliance measurements in a mammogram.
|
At the completion of 100 participants; approximately 4 months from study initiation
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 423-P-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Screening Mammogram
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
University of North Carolina, Chapel HillWithdrawnMammogram ScheduledUnited States
-
National University Health System, SingaporeCompletedMammogram ScheduledSingapore
-
Brigham and Women's HospitalNational Cancer Institute (NCI); Mayo Clinic; Albert Einstein College of Medicine and other collaboratorsCompletedMammographic Density | Abnormal MammogramUnited States
-
Micrima, Ltd.Completed
-
University of PennsylvaniaCompletedPeople Due for Mammogram | People Due for Colonoscopy | People Due for Blood Pressure Test | People Due for Cholesterol TestUnited States
-
Pamukkale UniversityThe Scientific and Technological Research Council of TurkeyActive, not recruitingCancer Screening | Men's Health ScreeningTurkey (Türkiye)
-
Menssana Research, Inc.University of Erlangen-Nürnberg; Zuyderland Medical Centre; Mount Vernon Cancer...Not yet recruitingBreast Cancer | Abnormal Mammogram, UnspecifiedNetherlands, Germany, United Kingdom
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); Massachusetts League of Community Health Centers and other collaboratorsNot yet recruitingTobacco Cessation | Cervical Cancer Screening | Breast Cancer Screening | Colon Cancer Screening
-
Max Planck Institute for Human DevelopmentDartmouth-Hitchcock Medical CenterCompleted